drugset / Trial / NCT03278522
Ramosetron Pre-treatment for PONV and QT Prolongation
RandomizedParallel-groupTriple-blindPrevention
Summary
Ramosetron is commonly used to prevent postoperative nausea and vomiting (PONV) in the Eastern Asia. The prolongation of QTc interval is a main side effect. In this study, the pre-treatment time of ramosetron to decrease PONV, and QTc prolongation is compared.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ramosetron | Small molecule | 0.6 mg | Intravenous |
Indications
No indication recorded.